Format

Send to

Choose Destination
Expert Rev Mol Med. 2002 May 14;4(12):1-11.

Hereditary transthyretin amyloidosis: molecular basis and therapeutical strategies.

Author information

1
Amyloid Unit, Institute for Cellular and Molecular Biology, University of Porto, R. Campo Alegre, 823. 4150-180 Porto, Portugal. mjsaraiv@ibmc.up.pt

Abstract

Transthyretin (TTR) is a transport protein for thyroid hormones and vitamin A and might have an important role in the nervous system. However, TTR can undergo a conformational change and form amyloid fibrils, in both acquired and hereditary forms of systemic amyloidosis. More than 80 TTR mutations have been associated with autosomal dominant amyloidosis, usually presenting with peripheral and autonomic neuropathy and/or cardiomyopathy. Major areas of research in TTR amyloidosis include: molecular mechanisms leading to fibril formation; mechanisms of fibril-induced cell death; modulators of phenotypic expression of the disease; and therapeutic strategies.

PMID:
14987380
DOI:
doi:10.1017/S1462399402004647
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Cambridge University Press
Loading ...
Support Center